St. Louis-based contract development and manufacturing organization focused on animal health formulations.
Vetio Animal Health provides contract development and manufacturing services exclusively for the animal health sector, producing formulations such as tablets, soft chews, spot-ons, and dermatology topicals. Founded in 1989 and headquartered in St. Louis, US, the company is led by CEO John Kane. In June 2021, Swedencare AB acquired Vetio for USD 181.5 mn, transitioning from Thompson Street Capital Partners. It is at the Seed stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign inWork at Vetio Animal Health? This is my company